SCHEMBL7018475

SCHEMBL7018475

O=C(Oc1cccc2c1Cc1ccccc1-2)N1CCOC(CO)C1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TP53 P04637 1/20 0.41
▸ PIK3CD O00329 1/20 0.40
▸ PIK3R2 O00459 1/20 0.40
▸ PIK3CA P42336 1/20 0.40
▸ PIK3CB P42338 1/20 0.40
▸ PIK3CG P48736 1/20 0.40
▸ PIK3R5 Q8WYR1 1/20 0.40
▸ PIK3R3 Q92569 1/20 0.40
▸ ALOX5AP P20292 1/20 0.40
▸ FEN1 P39748 1/20 0.40
▸ PDK1 Q15118 4/20 0.37
▸ SMN1; SMN2 Q16637 2/20 0.35
▸ POLB P06746 1/20 0.35
▸ BCHE P06276 1/20 0.34
▸ ALDH1A1 P00352 1/20 0.34
▸ GAA P10253 1/20 0.34
▸ NPC1 O15118 1/20 0.34
▸ RAB9A P51151 1/20 0.34
▸ EPHX1 P07099 1/20 0.33
▸ L3MBTL1 Q9Y468 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7018480 0.88 TP53 (0.41) TP53PIK3CDPIK3R2PIK3CAPIK3CB
SCHEMBL7022249 0.84 TP53 (0.42) TP53PDK1SMN1; SMN2POLBBCHE
SCHEMBL7016808 0.82 PDK1 (0.43) TP53PDK1SMN1; SMN2POLBBCHE
SCHEMBL20627245 0.79 TP53 (0.48) TP53PIK3CDPIK3R2PIK3CAPIK3CB
SCHEMBL7022253 0.72 TP53 (0.42) TP53PDK1SMN1; SMN2POLBBCHE
SCHEMBL8070682 0.71 PIK3CD (0.43) PIK3CDPIK3R2PIK3CAPIK3CBPIK3CG
SCHEMBL25764556 0.71 PIK3CD (0.43) PIK3CDPIK3R2PIK3CAPIK3CBPIK3CG
SCHEMBL25764551 0.71 PIK3CD (0.43) PIK3CDPIK3R2PIK3CAPIK3CBPIK3CG
SCHEMBL8840922 0.70 RAB9A (0.54) SMN1; SMN2BCHEALDH1A1NPC1RAB9A
SCHEMBL7016802 0.69 PDK1 (0.43) TP53PDK1SMN1; SMN2POLBBCHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1206265-B1 SRC KINASE INHIBITOR COMPOUNDS MERCK & CO INC (US) 2003-11-12 — — EP disclosed
US-6498165-B1 PYRIMIDINE COMPOUNDS; PROPHYLAXIS AND TREATMENT OF SUCH AS IMMUNE DISEASES, HYPERPROLIFERATIVE DISORDERS, CANCER, ANGIOGENSIS, ATHEROSCELEROSIS, GRAFT REJECTION, RHEUMATOID ARTHRITIS, PSORIASIS MERCK & CO., INC. 2002-12-24 — — US disclosed
EP-1194152-A4 SRC KINASE INHIBITOR COMPOUNDS MERCK & CO INC (US) 2002-11-06 — — EP disclosed
EP-1206265-A4 SRC KINASE INHIBITOR COMPOUNDS MERCK & CO INC (US) 2002-08-07 — — EP disclosed
EP-1206265-A1 SRC KINASE INHIBITOR COMPOUNDS Merck & Co., Inc. (US) 2002-05-22 — — EP disclosed
EP-1194152-A1 SRC KINASE INHIBITOR COMPOUNDS Merck & Co., Inc. (US) 2002-04-10 — — EP disclosed
US-6316444-B1 SRC kinase inhibitor compounds MERCK & CO., INC. 2001-11-13 — — US disclosed
WO-2001000214-A1 SRC KINASE INHIBITOR COMPOUNDS MERCK & CO., INC. (US) 2001-01-04 — — WO disclosed
WO-2001000213-A1 SRC KINASE INHIBITOR COMPOUNDS MERCK & CO., INC. (US) 2001-01-04 — — WO disclosed
Send feedback